Lumonus, a leader in AI powered radiation oncology workflow solutions, announced the close of its A$25 million Series B financing round. The round was led by Aviron Investment Management with continued participation from Oncology Ventures. This funding will support the integration of the Lumonus AI platform into health systems across the United States, Australia, and Europe. The investment enables Lumonus to expand its team and enhance oncology workflows.
Who to call at Lumonus, and when
A new round usually means Lumonus is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Lumonus raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Lumonus, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lumonus. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Lumonus
Location
702/100 WALKER ST
Sydney, New South Wales, Australia
About
Lumonus is transforming cancer care by empowering providers with user-centric software products and value-added services. Born from firsthand experience with the challenges of delivering quality cancer care globally, Lumonus understands the complexities of managing clinical teams, addressing patient needs, and navigating payor requirements. With a deep appreciation for teamwork, the company leverages its extensive provider experience to solve real-world challenges faced by clinics of all sizes. Driven by innovation, Lumonus is dedicated to redefining cancer care through technology and services that enhance efficiency, collaboration, and patient outcomes.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lumonus raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
SydneyBiotechnologyHealth CareArtificial IntelligenceMachine LearningHealth Diagnostics